IDO1 and cancer: To explore the role of IDO1 in mediating resistance, we thus established IDO1-overexpressing MC38 tumors (Supplemental Figure 6H), and, in parallel, we included an Ido1-knockout cancer model to examine the effects of our binary design rationale (Figure 6, J and K).